NL-OMON24191
Recruiting
Not Applicable
Double-blind placebo-controlled randomized study to determine the effectiveness of magnesium oxide to reduce the prostate motion.
niversity Medical Center Utrecht, The Netherlands0 sites184 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- 1. Prostate cancer
- Sponsor
- niversity Medical Center Utrecht, The Netherlands
- Enrollment
- 184
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prostate cancer patients scheduled for external beam radiotherapy using fiducial marker\-based position verification.
Exclusion Criteria
- •1\. Patients with known severe constipation;
- •2\. Patients who receive laxatives;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Alfentanil in CT-colonography.PainCt-colonographyColorectal cancerPolypsNL-OMON25320Academic Medical Center90
Completed
Not Applicable
Efficacy and safety of ezetimibe in young children with familial hypercholesterolemia.Familial hypercholesterolemiaNL-OMON25426Academic Medical Centre (AMC), Department of Vascular Medicine70
Recruiting
Not Applicable
Het effect van fenretinide op insulinegevoeligheid.ObesityMetabolic syndrome XInsulin resistanceFatty liverNL-OMON25232Academic Medical Center (AMC)20
Completed
Not Applicable
Randomized, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischemia.Refractory angina pectoris and documented myocardial ischemia.NL-OMON29227Departmartement of Cardiology,Leiden University Medical Center ,Leiden, the Netherlands50
Recruiting
Not Applicable
Repeated KLH immunization in healthy volunteersNL-OMON24998CHDR12